Advanced search
Most relevant results are first | Show most recent results first | Show use by person

Search only John DeasySearch all speeches

Results 4,461-4,480 of 5,388 for speaker:John Deasy

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: Does he wish to give evidence to the committee?

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: We requested that he clarify the reasons he would want to come before the committee. Has he given the clerk an indication as to why? I understand the clerk cannot speak.

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: I asked for a departmental note on this matter. There are issues arising with regard to the Office of Government Procurement in particular and to the construction of the tender. We are back into the same territory we were in that only a one year extension is being granted, such that a new tender will have to be drawn up and so on. In my opinion, the Office of Government Procurement did not...

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: The head of the Office of Government Procurement is the person who needs to come in.

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: I think we should do that. Is the Chairman agreeable to the departmental officials being asked to attend the meeting on 19 November with the Office of Government Procurement?

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: Do we know who will be representing the Office of Government Procurement on 19 November?

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: I suppose this is something that we can bring up with the HSE. My question is a positive one. We spoke to the Secretary General of the Department of Health a couple of weeks ago. He followed through on what we asked him to do, to firm up what we had proposed in committee here over the past year and to put together an independent panel to deal with reviews and reports that are commissioned...

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: Is there any point in asking Carlow IT to come in too, while we are dealing with these matters, or is that something that is completely removed?

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: I know it is different and we should finalise it. That is fair enough.

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: Is the Chairman referring to the investigations unit?

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: I have been corresponding with the Secretary General's office regarding the Tom Galvin case, on the suggestion of the clerk to this committee. The Department has provided me with a general timeline on how it intends to deal with the issue. The new steering group met Mr. Galvin and it believes that a recommendation or decision will be made in December. The Department has acted in that...

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: I am conscious that this is Deputy Costello's constituency and he knows a great deal more about this than I do having been involved in it for years. We are going to bring the Department in with regard to arts and heritage - it will be coming in with regard to the Aer Arann tender document - and surely we can ask the officials at the same meeting when we are going to raise Moore Street what...

Public Accounts Committee: Business of Committee (22 Oct 2015)

John Deasy: We said 19 November to deal with Aer Arann and the tender. Can we deal with it then?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: I welcome Mr. O'Brien and the other witnesses. I had not intended to raise this but I will. It relates to what Deputy Sean Fleming asked Mr. O'Brien with regard to the conference in Spain. One can ask questions about the guidelines and the policies around them without impugning anybody's integrity. It is fair to ask whether it is wise for the head of the HSE, which has a budget of...

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: That is fine.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: It paid Mr. O'Brien a fee which he gave to charity. Is that correct?

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: There was, therefore, a benefit.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: Okay, but there was a benefit.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: I am parking that and moving to the policy issue. Mr. O'Brien should proceed.

Public Accounts Committee: Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines
(22 Oct 2015)

John Deasy: I am parking that issue too. I wish to get to the root of the issue. Is it wise for the head of the Health Service Executive or any other HSE employee to accept a fee, even if it goes to charity, and expenses for attending a conference? We must bear a very important thing in mind, namely, that the HSE deals with these companies which supply services to it. This is, therefore, a pretty...

   Advanced search
Most relevant results are first | Show most recent results first | Show use by person

Search only John DeasySearch all speeches